These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 30553783)
1. Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting. Jayaraj A; Buck W; Knight A; Johns B; Raju S J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):195-202. PubMed ID: 30553783 [TBL] [Abstract][Full Text] [Related]
2. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction. Jayaraj A; Powell T; Raju S J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):325-333.e1. PubMed ID: 34358674 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting. Jayaraj A; Noel C; Kuykendall R; Raju S J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734 [TBL] [Abstract][Full Text] [Related]
5. Impact of native iliac vein aspect ratio on initial clinical presentation and outcomes following stenting for symptomatic chronic iliofemoral venous obstruction. Butts H; Jayaraj A J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101900. PubMed ID: 38677552 [TBL] [Abstract][Full Text] [Related]
6. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. Jayaraj A; Powell T; Raju S J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1408-1415. PubMed ID: 34098125 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of stent occlusion after iliocaval stenting. Jayaraj A; Crim W; Knight A; Raju S J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):56-64. PubMed ID: 30442577 [TBL] [Abstract][Full Text] [Related]
8. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes. Jayaraj A; Thaggard D; Lucas M J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):634-641. PubMed ID: 36731654 [TBL] [Abstract][Full Text] [Related]
9. Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Park JY; Ahn JH; Jeon YS; Cho SG; Kim JY; Hong KC Phlebology; 2014 Aug; 29(7):461-70. PubMed ID: 23761876 [TBL] [Abstract][Full Text] [Related]
10. Comparison between a dedicated venous stent and standard composite Wallstent-Z stent approach to iliofemoral venous stenting: Intermediate-term outcomes. Powell T; Raju S; Jayaraj A J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):82-90.e2. PubMed ID: 35872144 [TBL] [Abstract][Full Text] [Related]
11. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent. de Wolf MA; de Graaf R; Kurstjens RL; Penninx S; Jalaie H; Wittens CH Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):518-26. PubMed ID: 26187656 [TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction. Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730 [TBL] [Abstract][Full Text] [Related]
17. Midterm Results of Endovascular Treatment for Iliac Vein Compression Syndrome from a Single Center. Huang C; Yu G; Huang J Ann Vasc Surg; 2018 May; 49():57-63. PubMed ID: 29428534 [TBL] [Abstract][Full Text] [Related]
18. Patency and Clinical Outcomes of a Dedicated, Self-Expanding, Hybrid Oblique Stent Used in the Treatment of Common Iliac Vein Compression. Stuck AK; Kunz S; Baumgartner I; Kucher N J Endovasc Ther; 2017 Feb; 24(1):159-166. PubMed ID: 27831483 [TBL] [Abstract][Full Text] [Related]